[go: up one dir, main page]

AU2001266337A1 - Virus vector for transferring gene into renal cells - Google Patents

Virus vector for transferring gene into renal cells

Info

Publication number
AU2001266337A1
AU2001266337A1 AU2001266337A AU6633701A AU2001266337A1 AU 2001266337 A1 AU2001266337 A1 AU 2001266337A1 AU 2001266337 A AU2001266337 A AU 2001266337A AU 6633701 A AU6633701 A AU 6633701A AU 2001266337 A1 AU2001266337 A1 AU 2001266337A1
Authority
AU
Australia
Prior art keywords
virus vector
renal cells
transferring gene
gene
transferring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001266337A
Inventor
Masayuki Fukumura
Mamoru Hasegawa
Enyu Imai
Yoshitaka Isaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dnavec Research Inc
Original Assignee
Dnavec Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dnavec Research Inc filed Critical Dnavec Research Inc
Publication of AU2001266337A1 publication Critical patent/AU2001266337A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18811—Sendai virus
    • C12N2760/18841—Use of virus, viral particle or viral elements as a vector
    • C12N2760/18843—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001266337A 2000-06-27 2001-06-27 Virus vector for transferring gene into renal cells Abandoned AU2001266337A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000-197870 2000-06-27
JP2000197870 2000-06-27
PCT/JP2001/005513 WO2002000264A1 (en) 2000-06-27 2001-06-27 Virus vector for transferring gene into renal cells

Publications (1)

Publication Number Publication Date
AU2001266337A1 true AU2001266337A1 (en) 2002-01-08

Family

ID=18696137

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001266337A Abandoned AU2001266337A1 (en) 2000-06-27 2001-06-27 Virus vector for transferring gene into renal cells

Country Status (8)

Country Link
US (1) US20030170897A1 (en)
EP (1) EP1297852A4 (en)
KR (1) KR20030014392A (en)
CN (1) CN1281276C (en)
AU (1) AU2001266337A1 (en)
CA (1) CA2414077A1 (en)
HK (1) HK1052140A1 (en)
WO (1) WO2002000264A1 (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69638196D1 (en) * 1995-11-01 2010-07-22 Dnavec Research Inc RECOMBINANT SENDAI VIRUS
US6490775B1 (en) * 1999-04-23 2002-12-10 Veri-Tek Inc. Press operation verification system
US20030166252A1 (en) * 1999-05-18 2003-09-04 Kaio Kitazato Paramyxovirus-derived RNP
US7226786B2 (en) * 1999-05-18 2007-06-05 Dnavec Research Inc. Envelope gene-deficient Paramyxovirus vector
DK1211318T3 (en) 1999-09-06 2007-11-12 Dnavec Research Inc Paramyxoviruses comprising a modified transcription start sequence
US7314614B1 (en) 1999-11-02 2008-01-01 Dnavec Research, Inc. Recombinant sendai virus vector for introducing exogenous genes to airway epithelia
WO2001053491A1 (en) * 2000-01-19 2001-07-26 Dnavec Research Inc. Use of paramyxovirus vector in gene transfer into blood vessel
JPWO2001072340A1 (en) * 2000-03-30 2004-01-08 株式会社ディナベック研究所 AIDS virus vaccine using Sendai virus vector
JP4700888B2 (en) * 2000-06-01 2011-06-15 株式会社ディナベック研究所 Pseudotype retroviral vector containing a membrane protein with hemagglutinin activity
JP2002142770A (en) * 2000-11-08 2002-05-21 Dnavec Research Inc Paramyxovirus vector for transporting gene to circulatory system
US8263756B2 (en) 2001-04-06 2012-09-11 Chugai Seiyaku Kabushiki Kaisha Method of gene transfer via vascular system or ureter
AU2003234774A1 (en) * 2002-04-30 2003-11-17 Dnavec Research Inc. Drug- or gene-carrier composition having lowered hemagglutinin activity
AU2003261931A1 (en) * 2002-09-04 2004-03-29 Dnavec Research Inc. Process for producing virus vector containing membrane protein having sialic acid-binding activitiy in envelope with the use of gram-positive bacterium-origin neuraminidase
US20060104950A1 (en) * 2002-10-24 2006-05-18 Shinji Okano Methods of Tranducing genes into T cells
EP1598424A1 (en) * 2003-01-31 2005-11-23 Dnavec Research Inc. Paramyxovirus vector encoding ribozyme and utilization thereof
EP1642966B1 (en) * 2003-06-30 2010-03-03 Dnavec Research Inc. Minus strand rna viral vectors carrying a gene with altered hypermutable regions
JPWO2005071085A1 (en) * 2004-01-22 2007-09-06 株式会社ディナベック研究所 Method for producing viral vector
WO2007049752A1 (en) 2005-10-28 2007-05-03 Dnavec Corporation Gene transfer into airway epithelial stem cell by using lentiviral vector pseudotyped with rna virus or dna virus spike protein
US9259445B2 (en) * 2006-06-07 2016-02-16 Universidad Tecnica Federico Santa Maria Integrated implant system (IIS) biocompatible, biodegradable and bioactive, comprising a biocompatible sterile porous polymeric matrix and a gel, integrating in situ the tridimensional matrix structure
JP2009079042A (en) * 2007-09-07 2009-04-16 Univ Nagoya Recombinant vector for the treatment of nephrogenic diabetes insipidus and use thereof
CA2874316A1 (en) * 2012-05-03 2013-11-07 Indiana University Research And Technology Corporation Hydrodynamic methods for delivering fluids to kidney tissues and related materials and methods
AU2014311994A1 (en) 2013-08-30 2016-04-21 Indiana University Research & Technology Corporation Hydrodynamic method and apparatus for delivering fluids to kidney tissues
JP6854461B2 (en) * 2014-11-05 2021-04-07 国立大学法人九州大学 Viral vector, iPS cell preparation method and construct
US10676723B2 (en) 2015-05-11 2020-06-09 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
GB202217332D0 (en) * 2022-11-18 2023-01-04 Univ Bristol Methods
CN116585493A (en) * 2022-12-27 2023-08-15 华中科技大学同济医学院附属协和医院 Application of PRDM16 gene overexpression reagent in preparation of drugs for preventing or treating chronic kidney disease

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0864645B9 (en) * 1995-10-31 2006-03-22 Dnavec Research Inc. Negative-strand rna virus vector having autonomously replicating activity
DE69638196D1 (en) * 1995-11-01 2010-07-22 Dnavec Research Inc RECOMBINANT SENDAI VIRUS
KR20010074631A (en) * 1998-07-03 2001-08-04 가부시끼가이샤 디나벡 겡뀨쇼 (-)-Strand RNA Virus Vector for Nerve Cell
US6828138B1 (en) * 1998-08-11 2004-12-07 Dnavec Research Inc. Recombinant sendai virus vector including a gene encoding a chemokine
US7226786B2 (en) * 1999-05-18 2007-06-05 Dnavec Research Inc. Envelope gene-deficient Paramyxovirus vector
US20030166252A1 (en) * 1999-05-18 2003-09-04 Kaio Kitazato Paramyxovirus-derived RNP
US20020169306A1 (en) * 1999-05-18 2002-11-14 Kaio Kitazato Envelope gene-deficient paramyxovirus vector
US20030022376A1 (en) * 1999-05-18 2003-01-30 Kaio Kitazato Paramyxovirus-derived RNP
DK1211318T3 (en) * 1999-09-06 2007-11-12 Dnavec Research Inc Paramyxoviruses comprising a modified transcription start sequence
WO2001053491A1 (en) * 2000-01-19 2001-07-26 Dnavec Research Inc. Use of paramyxovirus vector in gene transfer into blood vessel
EP1170363B1 (en) * 2000-02-02 2007-11-21 Kaneda, Yasufumi Virus envelope vector for gene transfer
JPWO2001072340A1 (en) * 2000-03-30 2004-01-08 株式会社ディナベック研究所 AIDS virus vaccine using Sendai virus vector
CA2322057A1 (en) * 2000-05-18 2001-11-18 Dnavec Research Inc. Paramyxovirus vectors used for transfer of foreign genes
JP4700888B2 (en) * 2000-06-01 2011-06-15 株式会社ディナベック研究所 Pseudotype retroviral vector containing a membrane protein with hemagglutinin activity
KR20030042003A (en) * 2000-10-06 2003-05-27 가부시키가이샤 디나벡크 겐큐쇼 Paramyxovirus vector for transferring foreign gene into skeletal muscle
JP2002142770A (en) * 2000-11-08 2002-05-21 Dnavec Research Inc Paramyxovirus vector for transporting gene to circulatory system
EP1344829B1 (en) * 2000-11-27 2008-04-23 Dnavec Research Inc. Paramyxovirus vector encoding fibroblast growth factor 2 (fgf2) and use thereof

Also Published As

Publication number Publication date
HK1056693A1 (en) 2004-02-27
KR20030014392A (en) 2003-02-17
EP1297852A4 (en) 2004-12-29
CN1281276C (en) 2006-10-25
CA2414077A1 (en) 2002-01-03
US20030170897A1 (en) 2003-09-11
EP1297852A1 (en) 2003-04-02
CN1447700A (en) 2003-10-08
HK1052140A1 (en) 2003-09-05
WO2002000264A1 (en) 2002-01-03

Similar Documents

Publication Publication Date Title
AU2001266337A1 (en) Virus vector for transferring gene into renal cells
AU769385C (en) Virus envelope vector for gene transfer
AU2001280835A1 (en) Value transfer system for unbanked customers
AU2001259266A1 (en) System for functional gene discovery in plants
AU2001291656A1 (en) Gene silencing vector
AU2001286643A1 (en) Gene discovery using microarrays
AU2744901A (en) Cooperative error handling system
AU5215601A (en) Inflammation-related gene
EP1119065A3 (en) Fuel cell system
AU2001290273A1 (en) Paramyxovirus vector for transferring foreign gene into skeletal muscle
AU2002324989A1 (en) Utility capacity transfer system
AUPQ529000A0 (en) Toner characterization cell
AU3758199A (en) Peptides for efficient gene transfer
AU2001289943A1 (en) Complexes for transferring nucleic acids into cells
AU2001242625A1 (en) Gene sequence
AU2001245700A1 (en) Transfer microdissection
AU2001264247A1 (en) GASC1 gene
AU7318700A (en) Novel transaldolase gene
AUPQ749100A0 (en) New epilespy gene
AU2472501A (en) Methods for protein transfer
AU2001247444A1 (en) Erbeta-mediated gene expression
AU7567101A (en) Gene expression system
AUPQ521300A0 (en) Improved kit handling system
AU1452601A (en) Cholesterol transport gene
AU2001296607A1 (en) High efficiency regulatable gene expression system